ChromaDex, Inc. v. Elysium Health, Inc.

 
APPEAL NO.
22-1116
OP. BELOW
DCT
SUBJECT
Patent
AUTHOR
Prost

Question(s) Presented

  1. “May a claim that includes an isolated natural substance in a treatment formulation be denied patent eligibility on summary judgment when there are disputed fact issues as to whether the isolated substance and formulation have markedly different properties from the naturally occurring form of the substance and the potential for significant utility?”
  2. “May a court evaluating patent eligibility for a claim directed to a purported ‘natural product’ bypass Alice/Mayo step two, even though Alice states that the two-step framework applies to claims directed to ‘natural phenomena?’”

Posts About this Case